1. Home
  2. Labeler Index
  3. Pd-rx Pharmaceuticals, Inc.
  4. 43063-941
  5. Product Images: Sildenafil Citrate

Product Images Sildenafil Citrate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 10 images provide visual information about the product associated with Sildenafil Citrate NDC 43063-941 by Pd-rx Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

43063941 Label - 43063941

43063941 Label - 43063941

This is a package of Sildenafil tablets, each containing 50 mg of Sildenafil Citrate USP. The tablets are blue, round, and come in a container with 15 tablets. The lot number is D20C41 and they expire in September 2020. The product is from JINCORPORATED in Oklahoma City, OK. It is important to call a doctor if any side effects occur and to report them to the FDA. The instructions indicate the number of tablets to take each day but the frequency is not provided.*

chemical structure

chemical structure

figure 1

figure 1

The given text seems to be a clinical trial report of an experiment conducted on the effect of Sildenafil 100mg on blood pressure. The numbers indicate the systolic blood pressure in mmHg. The term 'Pre-Dose' suggests that the readings were taken before administering the dose, and 'Time post dose' may indicate the time elapsed after dosing. 'PLACEBO' and 'SLDENAFIL 100mg' are mentioned, which could indicate the experimental and control groups in the study. However, without further context, it is difficult to draw any definitive conclusions.*

figure 2

figure 2

The text describes a graph that shows the change in systolic blood pressure (SBP) in mmHg over time (in hours) postdose for two groups: one receiving Doxazosin and placebo, and the other receiving Doxazosin and Sildenafil 25 mg. It is not possible to determine the precise results from the given text.*

figure 3

figure 3

This appears to be a graph showing the change in SBP (systolic blood pressure) in mmHG, over time post-dose in hours, for two different treatments: "Doxazosin + Placebo" and "Doxazosin + Sildenafil 50 mg." The values on the x-axis range from 1 to 8, and the y-axis ranges from 0 to 40 mmHg.*

figure 4

figure 4

This text describes a graph showing the time after taking a medication containing Doxazosin and either Sildenafil or Placebo. The units of measurement on the graph are in mmHg, but the context of the text is not sufficient to provide further details or explanation.*

figure 5

figure 5

figure 6 1

figure 6 1

The text appears to represent numerical data related to patients and their scores, but without additional context or information, it is not possible to generate a useful description.*

figure 6 2

figure 6 2

figure 7

figure 7

This is a chart or table showing the percentage of patients who reported improvement while taking different doses of sildenafil citrate compared with a placebo. The doses of sildenafil citrate were 25mg, 50mg, and 100mg. The table shows that 100% of patients on the placebo reported improvement, while 82%, 74%, and 63% of patients on the different doses of sildenafil citrate reported improvement.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.